Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab
WU, C., MANCHEN, P., EDELMAN, A., HUSNAIN, M., KATSANIS, E., FUCHS, D., STEPHENS, L., KHURANA, S..
Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab.
Journal of Hematology, North America, 12,
dec. 2023. Available at: <https://thejh.org/index.php/jh/article/view/1195/785>. Date accessed: 16 Dec. 2025.